Acurx Pharmaceuticals, Inc. ACXP
Set alert
1.07 USD +0.03 +2.88%
At close · Nov 2
1.12 +0.05 +4.67%
After hours · Nov 2, 6:32 PM ET
1.05 Day range 1.11
1.04 52-week range 7.54
- YTD
- -57.03%
- 1 year
- -78.69%
- Open
- 1.08
- Prev close
- 1.04
- Mkt cap
- 5.85M
- Vol
- 143.67K
- Avg vol
- 119.78K
- EPS
- -2.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.05
- High
- 1.11
- Forward P/E
- -0.56
- Beta
- -1.72
- Short ratio
- 12.59
- Inst. own
- 11.96%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 1.46
- 200-d avg
- 2.00
- 1y target
- 11.19
Financial health
Altman Z-Score
-10.25 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 5
Valuation
P/E -0.5×
FY 2019 5y median -3.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.7×
FY 2019 5y median 5.9× FY 2025
P/FCF -0.5×
FY 2019 5y median -5.0× FY 2025
EV/EBITDA 0.5×
FY 2019 5y median -2.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -181.9%
FY 2019 5y median -20.2% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -151.2%
FY 2019 5y median -165.3% FY 2025
ROIC -153.6%
FY 2019 5y median -165.3% FY 2025
ROA -103.6%
FY 2019 5y median -129.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income 42.6%
FY 2019 FY 2025
EPS (diluted) 69.8%
FY 2019 FY 2025
Free Cash Flow 34.6%
FY 2019 FY 2025
Financial Health
Current Ratio 3.2×
FY 2019 5y median 3.2× FY 2025
Quick Ratio 3.2×
FY 2019 5y median 3.2× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.9×
FY 2019 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
